Drug
Zynrelef
Zynrelef: highest development phase Post-Market, developed by Heron Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Heron Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZYNRELEF 200Mg-6Mg Extended-Release Solution NCT05863221 | Post-Market | Post Operative Pain, Acute |
Latest
No recent events.
Follow Zynrelef on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.